1.1500
-0.0500
(-4.17%)
As of 9:30:00 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
4,440.7290
6,045.9860
10,290.6060
2,910.6050
1,019.8744
Operating Income
-4,440.7290
-6,045.9860
-10,290.6060
-2,910.6050
-1,019.8744
Net Non Operating Interest Income Expense
146.3920
253.5430
103.5890
-4.4510
-10.5963
Other Income Expense
3,557.6800
3,634.3780
2,468.1350
1,335.7820
23.0661
Pretax Income
-736.6570
-2,158.0650
-7,718.8820
-1,579.2740
-1,007.4046
Net Income Common Stockholders
-736.6570
-2,158.0650
-7,718.8820
-1,579.2740
-1,007.4046
Diluted NI Available to Com Stockholders
-736.6570
-2,158.0650
-7,718.8820
-1,579.2740
-1,007.4046
Basic EPS
0.12
-1.09
-4.71
-1.20
-1.34
Diluted EPS
0.12
-1.09
-4.71
-1.20
-1.34
Basic Average Shares
2,559.2870
1,981.7340
1,479.9130
1,094.1820
740.4470
Diluted Average Shares
2,559.2870
1,981.7340
1,479.9130
1,094.1820
740.4470
Total Expenses
4,440.7290
6,045.9860
10,290.6060
2,910.6050
1,019.8744
Net Income from Continuing & Discontinued Operation
-736.6570
-2,158.0650
-7,718.8820
-1,579.2740
-1,007.4046
Normalized Income
-4,294.3370
-5,792.4430
-10,187.0170
-2,915.0560
-1,030.4707
Interest Income
--
--
101.3668
--
--
Interest Expense
--
--
--
4.3905
10.5963
Net Interest Income
146.3920
253.5430
103.5890
-4.4510
-10.5963
EBIT
-4,440.7290
-6,045.9860
-10,290.6060
-2,910.6050
-996.8082
EBITDA
-4,325.2390
-5,906.2920
-10,232.4600
-2,896.3390
-980.7797
Reconciled Depreciation
115.4900
139.6940
58.1460
14.2660
16.0286
Net Income from Continuing Operation Net Minority Interest
-736.6570
-2,158.0650
-7,718.8820
-1,579.2740
-1,007.4046
Total Unusual Items Excluding Goodwill
3,557.6800
3,634.3780
2,468.1350
1,335.7820
23.0661
Total Unusual Items
3,557.6800
3,634.3780
2,468.1350
1,335.7820
23.0661
Normalized EBITDA
-7,882.9190
-9,540.6700
-12,700.5950
-4,232.1210
-1,003.8458
12/31/2020 - 11/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGNPF Algernon Pharmaceuticals Inc.
0.0540
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0100
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
+6.25%
BCT.TO BriaCell Therapeutics Corp.
5.95
+4.20%
BOLT Bolt Biotherapeutics, Inc.
0.3241
+0.97%
SLN Silence Therapeutics plc
2.3700
+8.22%
OGEN Oragenics, Inc.
0.1930
+9.04%
CMPX Compass Therapeutics, Inc.
1.6650
+0.91%
NNVC NanoViricides, Inc.
1.0999
+2.79%
BSEM BioStem Technologies, Inc.
10.99
+18.05%